Bernadett Blaskó
Semmelweis University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernadett Blaskó.
BMC Genetics | 2006
Ágnes Szilágyi; Bernadett Blaskó; Denes Szilassy; George Füst; Maria Sasvari-Szekely; Zsolt Ronai
BackgroundThe fourth component of human complement (C4), an essential factor of the innate immunity, is represented as two isoforms (C4A and C4B) in the genome. Although these genes differ only in 5 nucleotides, the encoded C4A and C4B proteins are functionally different. Based on phenotypic determination, unbalanced production of C4A and C4B is associated with several diseases, such as systemic lupus erythematosus, type 1 diabetes, several autoimmune diseases, moreover with higher morbidity and mortality of myocardial infarction and increased susceptibility for bacterial infections. Despite of this major clinical relevance, only low throughput, time and labor intensive methods have been used so far for the quantification of C4A and C4B genes.ResultsA novel quantitative real-time PCR (qPCR) technique was developed for rapid and accurate quantification of the C4A and C4B genes applying a duplex, TaqMan based methodology. The reliable, single-step analysis provides the determination of the copy number of the C4A and C4B genes applying a wide range of DNA template concentration (0.3–300 ng genomic DNA). The developed qPCR was applied to determine C4A and C4B gene dosages in a healthy Hungarian population (N = 118). The obtained data were compared to the results of an earlier study of the same population. Moreover a set of 33 samples were analyzed by two independent methods. No significant difference was observed between the gene dosages determined by the employed techniques demonstrating the reliability of the novel qPCR methodology. A Microsoft Excel worksheet and a DOS executable are also provided for simple and automated evaluation of the measured data.ConclusionThis report describes a novel real-time PCR method for single-step quantification of C4A and C4B genes. The developed technique could facilitate studies investigating disease association of different C4 isotypes.
Journal of Immunology | 2009
Beáta Tóth; Éva Garabuczi; Zsoly Sarang; György Vereb; György Vámosi; Daniel Aeschlimann; Bernadett Blaskó; Baliant Becsi; Ferenc Erdodi; Adam Lacy-Hulbert; Ailiang Zhang; Laura Falasca; Raymond B. Birge; Zoltán Balajthy; Gerry Melino; László Fésüs; Zsuzsa Szondy
Transglutaminase 2 (TG2), a protein cross-linking enzyme with many additional biological functions, acts as coreceptor for integrin β3. We have previously shown that TG2−/− mice develop an age-dependent autoimmunity due to defective in vivo clearance of apoptotic cells. Here we report that TG2 on the cell surface and in guanine nucleotide-bound form promotes phagocytosis. Besides being a binding partner for integrin β3, a receptor known to mediate the uptake of apoptotic cells via activating Rac1, we also show that TG2 binds MFG-E8 (milk fat globulin EGF factor 8), a protein known to bridge integrin β3 to apoptotic cells. Finally, we report that in wild-type macrophages one or two engulfing portals are formed during phagocytosis of apoptotic cells that are characterized by accumulation of integrin β3 and Rac1. In the absence of TG2, integrin β3 cannot properly recognize the apoptotic cells, is not accumulated in the phagocytic cup, and its signaling is impaired. As a result, the formation of the engulfing portals, as well as the portals formed, is much less efficient. We propose that TG2 has a novel function to stabilize efficient phagocytic portals.
Journal of Immunology | 2003
Eva Szegezdi; Ildikó Kiss; Ágnes Simon; Bernadett Blaskó; Uwe Reichert; Serge Michel; Matyas Sandor; László Fésüs; Zsuzsa Szondy
Negative selection refers to the selective deletion of autoreactive thymocytes. Its molecular mechanisms have not been well defined. Previous studies in our laboratory have demonstrated that retinoic acids, physiological ligands for the nuclear retinoid receptors, selectively inhibit TCR-mediated death under in vitro conditions, and the inhibition is mediated via the retinoic acid receptor (RAR) α. The present studies were undertaken to investigate whether ligation of RARα leads to inhibition of TCR-mediated death in vivo and to identify the molecular mechanisms involved. Three models of TCR-mediated death were studied: anti-CD3-mediated death of thymocytes in wild-type mice, and Ag- and bacterial superantigen-driven thymocyte death in TCR-transgenic mice expressing a receptor specific for a fragment of pigeon cytochrome c in the context of the Ek (class II MHC) molecule. Our data demonstrate that the molecular program of both anti-CD3- and Ag-driven, but not that of superantigen-mediated apoptosis involves up-regulation of nur77, an orphan nuclear receptor, and bim, a BH3-only member of the proapoptotic bcl-2 protein family, proteins previously implicated to participate in the negative selection. Ligation of RARα by the synthetic agonist CD336 inhibited apoptosis, DNA binding of nur77, and synthesis of bim induced by anti-CD3 or the specific Ag, but had no effect on the superantigen-driven cell death. Our data imply that retinoids are able to inhibit negative selection in vivo as well, and they interfere with multiple steps of the T cell selection signal pathway.
International Journal of Cancer | 2007
Éva Katalin Tóth; Judit Kocsis; Balázs Madaras; Adrienn Bíró; Zsuzsa Pocsai; George Füst; Bernadett Blaskó; István Karádi; Róza Ádány; Judit Laki
Many recent data indicate that some alleles encoded in the central major histocompatibility complex (MHC) region (Class III) of short arm of chromosome 6 may modify the risk of cancer development. Therefore we determined 4 single nucleotide polymorphisms (SNPs) of this region (TNF‐α −308 G > A, RAGE −429 T > C, HSP70‐2 −1267 A > G, LTA 252 A > G) in genomic DNA samples from 183 Hungarian patients with colorectal cancer and 141 age matched control subjects representing the Hungarian population of the same age and gender. No significant differences were found in either SNP tested. When, however, three‐ or four‐locus haplotypes consisting of known constituents of the so‐called 8.1 ancestral haplotype (8.1AH) were considered, marked differences were observed. Frequency of TNF‐α −308A, RAGE −429C, HSP70‐2 −1267G, LTA 252G (8.1AH) haplotype was significantly (p = 0.006) more frequent (19.1%) among patients than in the controls (7.7%). Age‐ and gender‐adjusted ratio of the 8.1AH carriers vs. non‐carriers to have colorectal cancer was 2.514 (1.130–5.594). This risk was higher in ≤67 years old subjects (4.073 (1.317–12.596)) and in females (3.771 (1.302–10.927). These findings—consistent with similar recent results with ovarian cancer—indicate that carriers of the 8.1AH, encoding for an altered immune response and known to be associated with alterations of several immune functions and autoimmune diseases have an increased risk for some cancer types. These findings may contribute to better understanding how the defense mechanisms against tumors could be enhanced/strengthened.
Biochemical and Biophysical Research Communications | 2003
Bernadett Blaskó; András Mádi; László Fésüs
Previous reports have suggested that protein disulfide isomerases (PDIs) have transglutaminase (TGase) activity. The structural basis of this reaction has not been revealed. We demonstrate here that Caenorhabditis elegans PDI-3 can function as a Ca(2+)-dependent TGase in assays based on modification of protein- and peptide-bound glutamine residues. By site-directed mutagenesis the second cysteine residue of the -CysGlyHisCys- motif in the thioredoxin domain of the enzyme protein was found to be the active site of the transamidation reaction and chemical modification of histidine in their motif blocked TGase activity.
International Archives of Allergy and Immunology | 2008
Gábor Széplaki; Lilian Varga; Anikó Szépvölgyi; Kornél Simon; Bernadett Blaskó; Eszter Nagy; István Karádi; George Füst; Henriette Farkas
Acquired angioedema (AAE) due to the functional deficiency of the C1 inhibitor (C1-INH) is a rare disease characterized by recurrent bouts of edema that involve subcutaneous tissues, the larynx or the gastrointestinal tract. In the present paper, we report the case of a male patient with symptoms of AAE and recurrent deep venous and arterial thrombosis. As a trigger of AAE in the present patient, we revealed primary antiphospholipid syndrome accompanied by antithrombin III deficiency, along with malignancy in the history, and angiotensin-converting enzyme inhibitor therapy. Although anti-C1-INH titers (type I AAE) were normal initially, we observed a sharp increase in anti-C1-INH titers (suggestive of type II AAE) during follow-up. It seems that thrombosis might worsen angioedematous attacks in functional C1-INH deficiency. Thrombophilia should be considered a provoking factor of AAE and should be carefully sought for in these patients, as the key to successful management of AAE is the effective treatment of the underlying disease.
Human Immunology | 2008
Gurvinder Kaur; Neeraj Kumar; Ágnes Szilágyi; Bernadett Blaskó; George Füst; Katalin Rajczy; Éva Pozsonyi; Adrienn Hossó; Gyözö Petrányi; Nikhil Tandon; N. K. Mehra
The classical AH8.1 (HLA-A1-B8-DR3-DQ2) is the most common Caucasian haplotype, associated with several autoimmune diseases, immunologic hyperreactivity and rapid progression to the acquired immunodeficiency syndrome. However, in Asian Indians, there are multiple unique B8-DR3 haplotypes that are associated with autoimmunity and differ significantly from the common Caucasian AH8.1. The Indian HLA-A1-B8-DR3 is therefore referred to as an AH8.1 variant. The aims of this study were to compare C4A and C4B copy numbers and to identify alleles in HSP70-2 and LTA in these haplotypes. The Indian B8-DR3 haplotypes differ from the Caucasian AH8.1 at C4A and HSP70-2 loci. The Indian B8-DR3 haplotypes have 1 copy each at C4A and C4B, while the Caucasian AH8.1 has 1 copy at C4B but no C4A gene. Moreover, the Indian and Caucasian B8-DR3 haplotypes had HSP70-2 1267 *A, and *G alleles, respectively. By contrast, the LTA 252 *G allele occurred both in the Indian and Caucasian haplotypes. The Indian haplotypes also contained Bf*F and TNF-308*G that were different from the Caucasian equivalents Bf*S and TNF-308*A. These differences and previous studies support the hypothesis that B8-DR3-DQ2 haplotypes in Asian Indian population might have originated independently of Caucasian AH8.1 selectively through recombination and mutations. Because autoimmune disease associations are shared among these otherwise diverse haplotypes, these data strongly suggest that some shared component(s) of all these associated haplotypes may be playing a key role in such associations.
Molecular Immunology | 2007
Judit Laki; Petra Kiszel; Ágnes Vatay; Bernadett Blaskó; Margit Kovács; Anna Körner; László Madácsy; László Blatniczky; Zsuzsa Almássy; Csaba Szalai; Katalin Rajczy; Éva Pozsonyi; István Karádi; Ádám Fazakas; Nóra Hosszúfalusi; Pál Pánczél; Gudmundur J. Arason; Yee Ling Wu; Bi Zhou; Yan Yang; C. Yung Yu; George Füst
Cytokine | 2006
Péter Harcos; Judit Laki; Petra Kiszel; Zoltán Széplaki; Zoltán Szolnoki; Margit Kovács; Béla Melegh; Gábor Széplaki; George Füst; Bernadett Blaskó
Molecular Immunology | 2007
Bernadett Blaskó; Gábor Széplaki; Lilian Varga; Zsolt Ronai; Zoltán Prohászka; Maria Sasvari-Szekely; Beáta Visy; Henriette Farkas; George Füst